Lifecare Full Year 2023 Earnings: kr0.29 loss per share (vs kr0.17 loss in FY 2022)

Lifecare (OB:LIFE) Full Year 2023 Results

Key Financial Results

• Net loss: kr35.3m (loss widened by 105% from FY 2022).
• kr0.29 loss per share (further deteriorated from kr0.17 loss in FY 2022).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Lifecare Earnings Insights

In the last 12 months, the only revenue segment was Patient Monitoring Equipment contributing kr13.1m. Over the last 12 months, the company's earnings were enhanced by non-operating gains of kr89.5k. Explore how LIFE's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 91% p.a. on average during the next 3 years, compared to a 7.0% growth forecast for the Medical Equipment industry in Europe.

Performance of the market in Norway.

The company's shares are down 6.2% from a week ago.

Risk Analysis

It's necessary to consider the ever-present spectre of investment risk. We've identified 6 warning signs with Lifecare (at least 3 which are potentially serious), and understanding them should be part of your investment process.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.